NCT06987539 2026-03-16
THYME
Amgen
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06414954 2026-03-10
SYNAPSE-MG
NMD Pharma A/S
Phase 2 Recruiting
NCT07284420 2026-02-09
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
argenx
Phase 2 Recruiting
NCT05067348 2025-05-01
tMG
Tang-Du Hospital
Phase 2 Recruiting